Literature DB >> 9175686

Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis.

F Cerneca1, G Ricci, R Simeone, M Malisano, S Alberico, S Guaschino.   

Abstract

OBJECTIVE: To establish the physiologic changes in the coagulation and fibrinolytic systems during normal pregnancy and puerperium. STUDY
DESIGN: One hundred and seventeen normal pregnant women were investigated in a longitudinal study involving five measurements: blood samples were collected at 10, 20, 30, 36 weeks and on the second day puerperium and were assayed for prothrombin time (PT expressed in INR), activated partial thromboplastin time (PTT), fibrinogen (FBG), antithrombin III activity (AT III), protein C activity (PC), protein S activity (PS), prothrombin fragments 1+2 (F1+2), type 1 plasminogen activator inhibitor activity (PAI) and tissue-plasminogen activator antigen (t-PA). Student t-test, One Way Analysis of Variance (ANOVA) and Bonferroni test were used for statistical analysis. P<0.05 (two tails) was assumed to indicate a significant difference.
RESULTS: Fibrinogen concentrations were always increased with respect to controls (P<0.001), while protein S was always decreased, with values averaging 60% of those of controls from the 10th week of pregnancy onwards (P<0.001). Variance analysis showed a statistically significant increase with gestational age for procoagulant factors (INR: P<0.001; FBG: P<0.001), a reduction for anticoagulants (PC: P<0.0001; PS: P<0.0001), and a rise for F1+2 (P<0.0001). With regard to fibrinolysis, there was an increase both for t-PA (P<0.0001) and PAI-1 (P<0.0001) during pregnancy. The t-PA values were always comprised in the normal range. PAI-1 were increased with respect to control values starting from 31st week. The most significant variations in the procoagulants (expressed by PT and FBG) were recorded up to the 20th week (P<0.001); from the 30th week onwards, they remained stable until after the delivery. The same was true for protein S levels (P<0.001), except that the difference between the 10th and the 20th weeks was not statistically significant. The level of F1+2 gradually increased throughout pregnancy (P<0.001), and then fell in the puerperium (P<0.001).
CONCLUSIONS: The parameters showing the greatest variation during pregnancy were PT, FBG, PS, F1+2 and PAI-1. The existence of a hypercoagulable state in pregnancy was suggested by the increased levels of F1+2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175686     DOI: 10.1016/s0301-2115(97)02734-6

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  29 in total

1.  Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy.

Authors:  J de Castro; J Sevillano; J Marciniak; R Rodriguez; C González-Martín; M Viana; O H Eun-suk; S Hauguel de Mouzon; E Herrera; M P Ramos
Journal:  Endocrinology       Date:  2011-09-13       Impact factor: 4.736

2.  Physiological changes of pregnancy and the Swansea criteria in diagnosing acute fatty liver of pregnancy.

Authors:  Adam Morton; Josephine Laurie
Journal:  Obstet Med       Date:  2018-04-16

Review 3.  Transfusion and coagulation management in major obstetric hemorrhage.

Authors:  Alexander J Butwick; Lawrence T Goodnough
Journal:  Curr Opin Anaesthesiol       Date:  2015-06       Impact factor: 2.706

4.  Coagulation and prothrombotic state parameters: a clinical analysis during early pregnancy.

Authors:  H Chen; L Zhou; L Meng; M Liu; J Tan; L Gao; J Zhang
Journal:  Ir J Med Sci       Date:  2011-08-02       Impact factor: 1.568

Review 5.  Neurological Complications of Pregnancy.

Authors:  H Steven Block
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

Review 6.  Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism.

Authors:  Meredith Turetz; Andrew T Sideris; Oren A Friedman; Nidhi Triphathi; James M Horowitz
Journal:  Semin Intervent Radiol       Date:  2018-06-04       Impact factor: 1.513

Review 7.  Identifying Key Intervention Opportunities During a Pregnancy Complicated by Diabetes: a Review of Acute Complications of Diabetes During Pregnancy.

Authors:  Paige K Bradley; Marissa Duprey; Kristin Castorino
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

Review 8.  Stroke and pregnancy: clinical presentation, evaluation, treatment, and epidemiology.

Authors:  Karrie E Grear; Cheryl D Bushnell
Journal:  Clin Obstet Gynecol       Date:  2013-06       Impact factor: 2.190

Review 9.  Venous thromboembolism in pregnancy-diagnosis, management, and treatment.

Authors:  R Kearsley; G Stocks
Journal:  BJA Educ       Date:  2021-01-06

10.  Vitamin D levels and C-reactive protein/albumin ratio in pregnant women with cerebral venous sinus thrombosis.

Authors:  Recep Yevgi; Nuray Bilge; Fatma Simsek; Alper Eren; Gamze Nur Cimilli Senocak
Journal:  J Thromb Thrombolysis       Date:  2021-08-03       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.